| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 2.468.005.083 $ | -109.355.259 $ | -3,5 % | 2.577.360.342 $ | +372.968.062 $ | +19,2 % | 1.967.127.562 $ | +775.842.956 $ | +99,4 % | |
| Frazier Life Sciences Management, L.P. | 552.396.879 $ | -53.498.372 $ | -8,8 % | 605.895.251 $ | +122.330.924 $ | +25,3 % | 483.564.327 $ | +178.807.553 $ | +58,7 % |
| Capital World Investors | 355.600.178 $ | +5.361.458 $ | +1,5 % | 350.238.720 $ | +70.880.819 $ | +25,4 % | 279.357.901 $ | +127.456.201 $ | +83,9 % |
| RA CAPITAL MANAGEMENT, L.P. | 312.381.607 $ | -30.305.752 $ | -8,8 % | 342.687.359 $ | +48.632.634 $ | +16,5 % | 294.054.725 $ | +107.771.894 $ | +57,9 % |
| FCPM III SERVICES B.V. | 294.456.789 $ | -28.240.623 $ | -8,8 % | 322.697.412 $ | +60.697.211 $ | +23,2 % | 262.000.201 $ | +69.452.634 $ | +36,1 % |
| Bain Capital Life Sciences Investors, LLC | 235.887.158 $ | -22.727.154 $ | -8,8 % | 258.614.312 $ | -47.948.176 $ | -15,6 % | 306.562.488 $ | +111.639.406 $ | +57,3 % |
| FMR LLC | 280.593.610 $ | +55.626.130 $ | +24,7 % | 224.967.480 $ | +67.543.747 $ | +42,9 % | 157.423.733 $ | +122.932.332 $ | +356,4 % |
| VIKING GLOBAL INVESTORS LP | 134.556.180 $ | -12.904.950 $ | -8,8 % | 147.461.130 $ | -36.703.057 $ | -19,9 % | 184.164.187 $ | +57.782.936 $ | +45,7 % |
| WELLINGTON MANAGEMENT GROUP LLP | 163.757.335 $ | -12.806.444 $ | -7,3 % | 176.563.779 $ | +62.231.396 $ | +54,4 % | |||
| DEERFIELD MANAGEMENT COMPANY, L.P. | 138.375.347 $ | -9.859.552 $ | -6,7 % | 148.234.899 $ | +25.302.564 $ | +20,6 % | |||
| 2.468.005.083 $ | -109.355.259 $ | -3,5 % | 2.577.360.342 $ | +372.968.062 $ | +19,2 % | 1.967.127.562 $ | +775.842.956 $ | +99,4 % | |